P42-TAT (Q3679804): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: translated_label)
(‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Property / beneficiary
 
Property / beneficiary: Q3768377 / rank
 
Normal rank

Revision as of 16:40, 24 November 2021

Project Q3679804 in France
Language Label Description Also known as
English
P42-TAT
Project Q3679804 in France

    Statements

    0 references
    56,400.0 Euro
    0 references
    255,600.0 Euro
    0 references
    22.07 percent
    0 references
    1 March 2017
    0 references
    28 February 2020
    0 references
    SATT AxLR SAS
    0 references
    0 references
    Le projet P42-TAT a pour but d’évaluer le potentiel préclinique d'un peptide de 36 acides aminés (P42-TAT) protecteur contre la maladie de Huntington. La maladie de Huntington est une maladie neurodégénérative rare due à l’expansion du domaine polyQ de la protéine huntingtine (Htt). Il sera mené par une équipe de recherche dirigée par Madame Florence MASCHAT au sein du laboratoire MMDN (Mécanismes Moléculaires dans les Démences Neurodégénératives ; Unité Inserm 1198) situé à l'Université de Montpellier. Ce programme de maturation est porté par la SATT AxLR dont le but est de valoriser les résultats de recherche issus des laboratoires publics de la région Occitanie auprès du monde socio-économique. Ses principales missions sont la détection, l'évaluation le financement de projets de maturation et leur transfert vers l'entreprise (PME, Start-up, grands comptes..). (French)
    0 references
    The aim of the P42-TAT project is to assess the preclinical potential of a 36 amino acid peptide (P42-TAT) protective against Huntington’s disease. Huntington’s disease is a rare neurodegenerative disease due to the expansion of the polyQ domain of huntingtin protein (HTT). It will be led by a research team led by Ms Florence Maschat within the MMDN laboratory (Moldecular Mechanisms in Neurodegenerative Demences; Inserm 1198) located at the University of Montpellier. This maturation programme is carried out by SATT AxLR, whose aim is to promote research results from public laboratories in the Occitanie region in the socio-economic world. Its main tasks are the detection, evaluation of the financing of maturation projects and their transfer to the enterprise (SMEs, Start-up, major accounts, etc.). (English)
    18 November 2021
    0 references

    Identifiers

    LR0011305
    0 references